{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:02:55Z","timestamp":1791270175908,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique (CNRS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Agence National de la Recherche-Maladies NeuroPsychiatriques","award":["ANR-2009-MNPS-026.01"],"award-info":[{"award-number":["ANR-2009-MNPS-026.01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.07.019","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T04:40:58Z","timestamp":1311655258000},"page":"278-288","source":"Crossref","is-referenced-by-count":70,"title":["Spadin as a new antidepressant: Absence of TREK-1-related side effects"],"prefix":"10.1016","volume":"62","author":[{"given":"H.","family":"Moha ou Maati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Veyssiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Labbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Heurteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Borsotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.07.019_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1540-8167.2007.00889.x","article-title":"A\u00a0novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome","volume":"18","author":"Aizawa","year":"2007","journal-title":"J.\u00a0Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib3","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/sj.emboj.7601116","article-title":"TREK-1, a K+ channel involved in polymodal pain perception","volume":"25","author":"Alloui","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib4","doi-asserted-by":"crossref","first-page":"17412","DOI":"10.1074\/jbc.M000445200","article-title":"TREK-2, a new member of the mechanosensitive tandem-pore K+ channel family","volume":"275","author":"Bang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/384078a0","article-title":"K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current","volume":"384","author":"Barhanin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib6","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.biocel.2009.04.002","article-title":"Neurotensin receptor-2 and -3 are crucial for the anti-apoptotic effect of neurotensin on pancreatic beta-TC3 cells","volume":"41","author":"Beraud-Dufour","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.biocel.2010.06.018","article-title":"Neurotensin is a regulator of insulin secretion in pancreatic beta-cells","volume":"42","author":"Beraud-Dufour","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib8","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/brain\/awp163","article-title":"TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system","volume":"132","author":"Bittner","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00004647-200207000-00007","article-title":"A\u00a0potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures","volume":"22","author":"Blondeau","year":"2002","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.107.154443","article-title":"Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel","volume":"101","author":"Blondeau","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0006-3223(98)00316-3","article-title":"Basic concepts in the study of diseases with complex genetics","volume":"45","author":"Burmeister","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib12","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1523\/JNEUROSCI.1017-05.2005","article-title":"Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway","volume":"25","author":"Chen","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib13","first-page":"137","article-title":"Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization","volume":"25","author":"Cheng","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/mol.105.018556","article-title":"Zinc and mercuric ions distinguish TRESK from the other two-pore-domain K+ channels","volume":"69","author":"Czirjak","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hbm.20858","article-title":"Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans","volume":"31","author":"Dillon","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1445-5994.2005.00850.x","article-title":"QTc abnormalities in deliberate self-poisoning with moclobemide","volume":"35","author":"Downes","year":"2005","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.2009.00371.x","article-title":"Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks)","volume":"159","author":"Ducroq","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib18","first-page":"729","article-title":"Riluzole improves functional recovery after ischemia in the rat retina","volume":"40","author":"Ettaiche","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1540-8167.2004.03534.x","article-title":"Drug-induced torsades de pointes and implications for drug development","volume":"15","author":"Fenichel","year":"2004","journal-title":"J.\u00a0Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib20","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1002\/j.1460-2075.1996.tb01077.x","article-title":"Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel","volume":"15","author":"Fink","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/jcbfm.1995.19","article-title":"Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat","volume":"15","author":"Golanov","year":"1995","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","article-title":"The economic burden of depression in the United States: how did it change between 1990 and 2000?","volume":"64","author":"Greenberg","year":"2003","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.hrthm.2005.07.017","article-title":"Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians","volume":"2","author":"Heist","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib24","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1073\/pnas.92.10.4666","article-title":"Essential role of adenosine, adenosine A1 receptors and KATP channels in cerebral ischemic preconditioning","volume":"92","author":"Heurteaux","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib25","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/sj.emboj.7600234","article-title":"TREK-1, a K(+) channel involved in neuroprotection and general anesthesia","volume":"23","author":"Heurteaux","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2005.08.083","article-title":"Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia","volume":"137","author":"Heurteaux","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/nn1749","article-title":"Deletion of TREK-1, a background potassium channel, results in a depression-resistant phenotype","volume":"9","author":"Heurteaux","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn2117","article-title":"The neuronal background K2P channels: focus on TREK1","volume":"8","author":"Honore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004240100626","article-title":"Localization of TREK-2 K+ channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi","volume":"442","author":"Kim","year":"2001","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib30","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.2174\/1381612054546824","article-title":"Physiology and pharmacology of two-pore domain potassium channels","volume":"11","author":"Kim","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.2216","article-title":"A\u00a0dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura","volume":"16","author":"Lafreniere","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-5223(99)70367-3","article-title":"Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping","volume":"117","author":"Lang-Lazdunski","year":"1999","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0741-5214(03)00473-7","article-title":"Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats","volume":"38","author":"Lang-Lazdunski","year":"2003","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib34","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/emboj\/19.8.1784","article-title":"Polyunsaturated fatty acids are potent neuroprotectors","volume":"19","author":"Lauritzen","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib35","doi-asserted-by":"crossref","first-page":"32068","DOI":"10.1074\/jbc.M302631200","article-title":"K+-dependent cerebellar granule neuron apoptosis. Role of task leak K+ channels","volume":"278","author":"Lauritzen","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib36","first-page":"793","article-title":"Molecular and functional properties of two pore domain potassium channels","volume":"279","author":"Lesage","year":"2000","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/FPC.0b013e32832cbe61","article-title":"Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment","volume":"19","author":"Liou","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib38","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1213\/01.ANE.0000136849.07384.44","article-title":"Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics","volume":"99","author":"Liu","year":"2004","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib39","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1074\/jbc.275.14.10128","article-title":"Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK","volume":"275","author":"Maingret","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/gast.2002.36000","article-title":"Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line","volume":"123","author":"Martin","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib41","doi-asserted-by":"crossref","first-page":"26273","DOI":"10.1074\/jbc.273.41.26273","article-title":"The 100-kDa neurotensin receptor is gp95\/sortilin, a non-G-protein-coupled receptor","volume":"273","author":"Mazella","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib42","doi-asserted-by":"crossref","first-page":"e1000355","DOI":"10.1371\/journal.pbio.1000355","article-title":"Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design","volume":"8","author":"Mazella","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/emboj\/18.3.595","article-title":"Propeptide cleavage conditions sortilin\/neurotensin receptor-3 for ligand binding","volume":"18","author":"Munck Petersen","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib45","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1001\/jama.294.23.2975","article-title":"Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice","volume":"294","author":"Napolitano","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib47","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.1074\/jbc.274.13.8832","article-title":"Sortilin\/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase","volume":"274","author":"Nielsen","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib48","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/emboj.2009.57","article-title":"The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception","volume":"28","author":"Noel","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(02)00597-7","article-title":"Two-pore domain K+ channels-molecular sensors","volume":"1566","author":"O\u2019Connell","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib50","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0166-2236(00)01810-5","article-title":"Properties and modulation of mammalian 2P domain K+ channels","volume":"24","author":"Patel","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib52","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1093\/emboj\/17.15.4283","article-title":"A\u00a0mammalian two pore domain mechano-gated S-like K+ channel","volume":"17","author":"Patel","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib53","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/npp.2008.6","article-title":"Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(\u2217)D study","volume":"33 (12)","author":"Perlis","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib54","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/sj.emboj.7601437","article-title":"AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels","volume":"25","author":"Sandoz","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib55","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1523\/JNEUROSCI.1962-08.2008","article-title":"Mtap2 is a constituent of the protein network that regulates twik-related K+ channel expression and trafficking","volume":"28","author":"Sandoz","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1085\/jgp.96.1.195","article-title":"Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents","volume":"96","author":"Sanguinetti","year":"1990","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/384080a0","article-title":"Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel","volume":"384","author":"Sanguinetti","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1602\/neurorx.2.4.590","article-title":"Innovative approaches for the development of antidepressant drugs: current and future strategies","volume":"2","author":"Schechter","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.7.2.181","article-title":"Sudden cardiac death secondary to antidepressant and antipsychotic drugs","volume":"7","author":"Sicouri","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib60","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1523\/JNEUROSCI.21-19-07491.2001","article-title":"Cns distribution of members of the two-pore-domain (KCNK) potassium channel family","volume":"21","author":"Talley","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib61","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/377340a0","article-title":"Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator","volume":"377","author":"Tsirka","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib62","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/11318880-000000000-00000","article-title":"Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly","volume":"26","author":"Vieweg","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuropharm.2011.07.019_bib63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.019_bib64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneurol.2010.166","article-title":"Migraine: familial migraine with aura is associated with a mutation in the TRESK potassium channel","volume":"6","author":"Wood","year":"2010","journal-title":"Nat. Rev. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T02:42:53Z","timestamp":1712630573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811002954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811002954"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.019","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}